These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4919168)

  • 21. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.
    Martin C; Williams A; Hernandez-Pando R; Cardona PJ; Gormley E; Bordat Y; Soto CY; Clark SO; Hatch GJ; Aguilar D; Ausina V; Gicquel B
    Vaccine; 2006 Apr; 24(17):3408-19. PubMed ID: 16564606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cyclophosphamide in animal experiments on tuberculosis].
    Ullmann U
    Zentralbl Bakteriol Orig; 1969; 209(3):377-82. PubMed ID: 4985426
    [No Abstract]   [Full Text] [Related]  

  • 24. [An immunofluorescent and serologic study of early reactions to the administration of BCG and H37Rv mycobacteria].
    Averbakh MM; Gogebashvili NV; Litvinov VI; Romanova RIu
    Biull Eksp Biol Med; 1968 Aug; 66(8):33-6. PubMed ID: 4921083
    [No Abstract]   [Full Text] [Related]  

  • 25. Tuberculosis in fennec foxes.
    Himes EM; Luchsinger DW; Jarnagin JL; Thoen CO; Hood HB; Ferrin DA
    J Am Vet Med Assoc; 1980 Nov; 177(9):825-6. PubMed ID: 7005205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STUDIES ON UNCLASSIFIED MYCOBACTERIA. II. IMMUNOGENICITY OF UNCLASSIFIED MYCOBACTERIA.
    SATAKE O
    Sci Rep Res Inst Tohoku Univ Med; 1963 Mar; 11():176-86. PubMed ID: 14053860
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical evaluation of the recombinant 38 kDa protein of Mycobacterium tuberculosis.
    He XY; Luo YA; Zhang XG; Liu YD; Wang ZY; Luo FZ; Zhang JP; Wang Q; Yan SM; Wang YJ; Ma LF; Guo J; Dong YJ; Huang XY; Zhuang YH
    Scand J Infect Dis; 2008; 40(2):121-6. PubMed ID: 17852901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tackling the problem of tuberculosis in cattle and people.
    Vet Rec; 2003 May; 152(20):608-10. PubMed ID: 12790163
    [No Abstract]   [Full Text] [Related]  

  • 29. [Tissue reactions caused by atypical mycobacteria in experimental animals. Evaluation pathogenicity. II. Late reactions].
    Michalik M
    Gruzlica; 1966 Jul; 34(7):619-25 contd. PubMed ID: 4959486
    [No Abstract]   [Full Text] [Related]  

  • 30. Independent transcription of glutamine synthetase (glnA2) and glutamine synthetase adenylyltransferase (glnE) in Mycobacterium bovis and Mycobacterium tuberculosis.
    Hotter GS; Mouat P; Collins DM
    Tuberculosis (Edinb); 2008 Sep; 88(5):382-9. PubMed ID: 18440867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tuberculostatic active N,N'-diarylthioureas. 2].
    Wagner WH; Winkelmann E
    Arzneimittelforschung; 1969 May; 19(5):719-30. PubMed ID: 4895500
    [No Abstract]   [Full Text] [Related]  

  • 32. Experimental chemotherapy of mycobacterioses provoked by atypical mycobacteria.
    Burjanová B; Urbancik R
    Bibl Tuberc; 1970; 26():154-88. PubMed ID: 4983240
    [No Abstract]   [Full Text] [Related]  

  • 33. [The feasibility of using the fluorescent antibody technic in immunologic studies of tuberculosis].
    Gogebashvili NV; Averbakh MM
    Biull Eksp Biol Med; 1967 Sep; 64(9):71-4. PubMed ID: 4988303
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
    J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance of various strains of mycobacteria to killing by activated macrophages in vivo.
    Orme IM; Collins FM
    J Immunol; 1983 Sep; 131(3):1452-4. PubMed ID: 6411817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Establishment of the guinea pig model of synovial tuberculosis of knee joint by mycobacterium tuberculosis H37Rv infection].
    Li WL; Song YM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):804-6, 809. PubMed ID: 17037758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [AGE-SPECIFIC PECULIARITIES OF MORPHOLOGICAL CHANGES IN THE ORGANS OF GUINEA PIGS INFECTED BY MYCOBACTERIUM TUBERCULOSIS BOVIS].
    ZHELEV V; DIAKOV L
    Arkh Patol; 1964; 26():45-8. PubMed ID: 14240620
    [No Abstract]   [Full Text] [Related]  

  • 38. Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations.
    Basaraba RJ; Izzo AA; Brandt L; Orme IM
    Vaccine; 2006 Jan; 24(3):280-6. PubMed ID: 16153758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The protective activity of mycobacterial antigens. 3. Protective activity of killed mycobacterial bodies].
    Stavri D; Anagnoste V; Drăghici D
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):91-101. PubMed ID: 4936247
    [No Abstract]   [Full Text] [Related]  

  • 40. The immunological and epidemiological significance of environmental mycobacteria on leprosy and tuberculosis control.
    Pallen MJ
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):231-45. PubMed ID: 6427125
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.